Tue, March 3, 2020
Mon, March 2, 2020
Fri, February 28, 2020
Thu, February 27, 2020
Wed, February 26, 2020
Tue, February 25, 2020
Mon, February 24, 2020
Fri, February 21, 2020

Charles Duncan Reiterated (ACAD) at Buy with Increased Target to $75 on, Feb 27th, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-75-on-feb-27th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Charles Duncan of Cantor Fitzgerald, Reiterated "ACADIA Pharmaceuticals Inc." (ACAD) at Buy with Increased Target from $70 to $75 on, Feb 27th, 2020.

Charles has made no other calls on ACAD in the last 4 months.



There is 1 other peer that has a rating on ACAD. Out of the 1 peers that are also analyzing ACAD, 0 agree with Charles's Rating of Hold.



This is the rating of the analyst that currently disagrees with Charles


  • Yatin Suneja of "Guggenheim" Initiated at Strong Buy and Held Target at $60 on, Monday, December 16th, 2019

Publication Contributing Sources